Am 20. und 21. Oktober 2022 feierte Excelsus Structural Solutions (ESS) sein 10-jähriges Bestehen mit einem erfolgreichen zweitägigen Event im Park Innovaare....
A platform to discuss high-level topics with the pharmaceutical industry
(This information is only available in English)
Novartis (Switzerland) and Alphora (Canada) joined the case study program conducted as part of the Second...
InterAx partners with Lundbeck to identify better pharmaceutical compounds
InterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...
PARK INNOVAARE welcomes Excelsus Structural Solutions
Excelsus Structural Solutions (Swiss) AG, Villigen, a spin-off company of the Paul Scherrer Institute (PSI), has moved to PARK INNOVAARE’s deliveryLAB....
leadXpro one year in operation: all goals achieved, and even more!
Today, leadXpro AG, one of PARK INNOVAARE’s residents, celebrates its first anniversary and breathtaking development as a company in its first year of...
INNOVATION in PRACTICE 2017: technologies and products in focus
Innovation cannot be planned. But it can be achieved faster and more effectively when the innovation process is being managed properly. For the second...
Collaborations speed up innovation. InterAx Biotech AG, a spin-off of the Paul Scherrer Institute (PSI) and ETH Zurich, based at PARK INNOVAARE, and Professor...
Excelsus Structural Solutions (ESS): Collaborates with Improved Pharma LLC
Excelsus Structural Solutions (ESS) is proud to announce a collaboration with Improved Pharma LLC (co-founded by Stephen Byrn, Professor at Purdue University,...
Excelsus invites pharma companies to explore for free the possibilities of synchrotron X-ray powder diffraction
The second annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop, organized together with the 16th Pharmaceutical Powder...